Company Search:
Advanced Search
Sponsored Links
Adimmune Corporation Company Snapshot
Adimmune Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adimmune with three other companies in this sector in TAIWAN : EirGenix Inc (2020 sales of 1.07 billion Taiwanese Dollars [US$38.34 million] of which 100% was Antibody and Protein Medicine Developmen), Syn-Tech Chem. & Pharm. Co., Ltd. (983.79 million Taiwanese Dollars [US$35.19 million] of which 100% was Sales revenue), and Bionet Corp. (806.58 million Taiwanese Dollars [US$28.85 million] ).

Sales Analysis. Adimmune reported sales of 1.87 billion Taiwanese Dollars (US$66.86 million) for the year ending December of 2020. This represents an increase of 43.8% versus 2019, when the company's sales were 1.30 billion Taiwanese Dollars . This was the third consecutive year of growth at Adimmune. Sales of Semi Finished Products Sales saw an increase that was more than double the company's growth rate: sales were up 3,860.4% in 2020, from 318,000.00 Taiwanese Dollars to 12.59 million Taiwanese Dollars . Adimmune also saw significant increases in sales in Finished Products Sales (up 88.8% to 1.36 billion Taiwanese Dollars ) . Not all segments of Adimmune experienced an increase in sales in 2020: sales of Others Income fell 98.7% to 24,000.00 Taiwanese Dollars . (However, this segment's sales were only a very small portion of the company's overall sales). Adimmune also experienced decreases in sales in Filling Service Income (down 14.0% to 496.21 million Taiwanese Dollars ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Adimmune Corporation
  Stock Performance Chart for Adimmune Corporation
  Stock Data: Recent Stock Performance:
  Current Price (5/14/2021): 57.60
(Figures in Taiwanese Dollars )
1 Week 13.8%   13 Weeks 3.0%  
4 Weeks n/a   52 Weeks 32.9%  
Adimmune Corporation Key Data:
  Ticker: 4142 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 1,869,147,000
(Year Ending Jan 2021).
Employees: 503
  Currency: Taiwanese Dollars Market Cap: 24,739,660,800
  Fiscal Yr Ends: December Shares Outstanding: 429,508,000
  Share Type: Gu Closely Held Shares: 145,560,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.